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Growth Restriction and Systemic
Immune Development in Preterm
Piglets
Ole Bæk, Per Torp Sangild, Thomas Thymann and Duc Ninh Nguyen*
Section for Comparative Pediatrics and Nutrition, Faculty of Health and Medical Sciences, University of Copenhagen,
Frederiksberg, Denmark
Background: Many preterm infants are born with growth restriction (GR) following
maternal or fetal complications before birth. Such infants may continue to grow slowly
after birth, regardless of birth weight (BW), due to morbidities related to their immature
organs. Severe GR increases the susceptibility to infections, but it is not clear if this is a
consequence of impaired systemic immunity or other factors, such as prolonged hospital
stay or poor mucosal barrier function. Using preterm pigs as models for preterm infants,
we hypothesized that moderate GR, exerting limited clinical effects, does not influence
systemic immune development.
Methods: Preterm pigs were delivered by cesarean section and fed bovine milk diets
until 19 d. Piglets with fetal growth restriction (F-GR, the lowest 25% of BW, n = 27,
excluding those with BW <350 g) and postnatal growth restriction (P-GR, the lowest
25% of postnatal growth rate, n = 24) were compared with their corresponding controls
(F-CON, n = 92, and P-CON, n = 85, respectively). Organ weights were determined
and blood collected for assessment of clinical status (blood chemistry and hematology).
For a subgroup (n = 58), in depth analyses of neutrophil function, T cell counts, plasma
cytokine levels, and leucocyte gene expression were performed.
Results: For F-GR pigs, adrenal gland weight was increased and bone mineral content
decreased at 19 d. Total leucocyte levels were lower at birth and interleukin-10 levels
increased at d 8–10. In P-GR pigs, total leucocyte, neutrophil, monocyte, and eosinophil
counts along with helper T cell fractions were elevated at 8–19 d of age, while the fraction
of neutrophils with phagocytic capacity was reduced. Diarrhea and all remaining organ
weights, blood chemistry, and immune variables were not affected by F-GR or P-GR.
Conclusion: Moderate GR before and after preterm birth has limited effect on
systemic immune development in preterm pigs, despite marginal effects on immune cell
populations, adrenocortical function, and body composition. Similar responses may be
observed for preterm infants with moderate fetal and postnatal growth restriction.
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BACKGROUND
Preterm infants (<37 weeks of gestation) have an increased
risk of developing life-threatening infections and up to 40%
develop sepsis in the neonatal period (1). This may be related
to an underdeveloped immune system, inadequate transfer
of maternal antibodies, but also to iatrogenic interventions,
such as mechanical ventilation and vascular catheterization
(1, 2). Antenatal factors, leading to slow fetal growth, may
also play a role in increasing the risk of postnatal infection
(3). Severely impeded fetal growth, resulting in intra uterine
growth restriction (IUGR, defined as <10% of the body
weight percentile), is a consequence of placental insufficiency or
medical conditions, such as preeclampsia, uterine complications,
or maternal/fetal infections (4). These infants show reduced
leukocyte, lymphocyte, and neutrophil counts at birth (5, 6)
and leukocytes exhibited reduced capacity to be activated by
lipopolysaccharide following ex vivo whole blood challenge (3).
Likewise, newborn infants show higher tolerable bacterial loads
than adults during bacteremia, possibly as a result of energy
constraints (7), which may be exacerbated after IUGR. Together
this may be a cause for their increased risk of neonatal sepsis
and later mortality, compared with infants born with a normal
body weight for their gestational age (1, 8–10). IUGR infants
have also been shown to have reduced thymus size at birth, a
prognostic factor for later sepsis risk (11, 12). Adolescents born
IUGR have lower levels of plasma thymopoietin (13), indicating
long term effects of IUGR on thymus function, while any IUGR
related reduction in plasma immunoglobulin levels at birth may
disappear within the first year (14). Despite these results, the
immune effects of different degrees of fetal growth restriction
after preterm birth remain poorly understood. Even without
IUGR, preterm birth is associated with low blood cell counts and
immature blood cell functions (2), and the “double hit” of IUGR
and preterm birth may either increase or decrease the immune
deficits documented for IUGR infants born at full term.
In addition to poor prenatal growth, a major proportion of
preterm infants experience postnatal growth restriction (15).
After birth, preterm infants have higher nutritional requirements
than term infants and have a high risk of feeding intolerance
due to an immature gut, leading to difficulties in achieving
growth rates that resemble those in utero (15, 16). Alleviating
Abbreviations: IUGR, Intrauterine growth restriction; EUGR, Extrauterine
growth restriction; PN, Parenteral nutrition; F-GR, Fetal growth restriction
(Group name); F-CON, Fetal growth restriction control (Group name); P-GR,
Postnatal growth restriction (Group name); P-CON, Postnatal growth restriction
control (Group name); MFI, Median fluorescent index; qPCR, Quantitative
polymerase chain reaction; TNFA, Tumor necrosis factor alpha (gene); IL4,
Interleukin-4 (gene); IL6, Interleukin-6 (gene); IL10, Interleukin-10 (gene); IFNG,
Interferon gamma (gene); GATA, GATA binding protein-3 (gene); TBET, T-box
transcription factor TBX21 (gene); TLR2, Toll-like receptor 2 (gene); TLR4, Toll-
like receptor 4 (gene); HPRT1, Hypoxanthine Phosphoribosyltransferase 1 (gene);
IL-2, Interleukin-2; IL-6, Interleukin-6; IL-10, Interleukin-10; TNF-α, Tumor
necrosis factor alpha; CRP, C reactive protein; ELISA, Enzyme linked immune
assay; MCHC, Mean cellular hemoglobin concentration; MCV, Mean cellular
volume;MPV,Mean platelet volume;MPC,Mean platelet component, BUN, Blood
urea nitrogen; ALAT, Alanine aminotransferase; AST, Aspartate aminotransferase;
GGT, Gamma glutaminyl transferase.
or preventing this extra uterine growth restriction (EUGR) may
be critical for later neurodevelopment (17), but it is not clear
if EUGR is associated with defects in other critical functions,
such as immunity. Children have higher baseline levels of
inflammatory cytokines, if exposed to EUGR in infancy (18), and
malnutrition induced EUGR may affect immunity in children in
low-income countries (19). For preterm infants, fortification of
mother’s ownmilk may be required to provide adequate amounts
of nutrients, but even with adequate nutrient intake, preterm
infants may experience slow growth, indicating that multiple
factors lead to EUGR (15), not only low nutrient intake, low birth
weight, and shortened gestation (20, 21).
Studies in full term piglets have contributed important
information about the postnatal consequences of IUGR on
physiological functions, including immunity (22–25). Much
less is known for preterm pigs or infants, and especially for
more moderate growth restriction before or after birth. The
immature status of such newborns may render themmore or less
susceptible to the consequences (metabolic, endocrinological,
inflammatory, or other) of moderate growth restriction. Using
preterm pigs as a model for preterm infants, we hypothesized that
moderate fetal and postnatal growth restriction, represented by
individuals with the lowest 25% birth weight or postnatal growth
rates, and excluding any pigs with extremely low birth weight,
would not show deficient organ growth or immune development,
relative to remaining litter-mate controls. Growth restricted
pigs were selected from a cohort of 7 l of preterm pigs reared
for 19 days for recording of body composition, hematological,
biochemical, and immune parameters.
METHODS
Animals and Experimental Design
Using three separate animal experiments with similar design,
we identified a cohort of preterm piglets to investigate the
impact of fetal and postnatal growth restriction. The experiments
were all performed in accordance to the principals of the Basel
Declaration and approved by the Danish National Committee
of Animal Experimentation (2009/561-1731). A total of 125
piglets from 7 litters (Landrace × Yorkshire × Duroc, Gadbjerg,
Denmark) were born prematurely by cesarean section at day
106 (90% gestation, term at 117 ± 2 days). Immediately after
birth, piglets were individually housed in heated incubators (37–
38◦C) and resuscitated with mechanical ventilation, if required.
Four piglets died of respiratory failure before randomization,
leaving 121 (54% male) piglets for the cohort study. While still
anesthetized from the cesarean section, each animal was prepared
with an orogastric catheter for enteral feeding and an umbilical
arterial catheter for parenteral nutrition and blood sampling.
All piglets were passively immunized by systemic infusion of
maternal plasma (total of 25 mL/kg, in three boluses within the
first 24 h).
Piglets were fed increasing amounts (16–180 ml/kg/day) of
bovine milk fortified with bovine colostrum (Biofiber Damino,
Gesten, Denmark), whey protein concentrate and/or human
milk oligosaccharide fractions (all products from Arla foods
ingredients, Viby, Denmark) until postnatal day 19. All pigs
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TABLE 1 | Study overview.
Study characteristics Feeding volumes (ml/kg/day)
Litters N Blood sample
(days)
Immune
subgroup*
Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7-8 Day 9 Day 10–15 Day 16–19
1 10 1♦, 8◦ & 19 Yes 32 48 64 96 96 112 128 144 160 180
2 10 1♦, 8◦ & 19 Yes 32 48 64 96 96 112 128 144 160 180
3 23 1♦, 8◦ & 19 Yes 32 48 64 96 96 112 128 144 160 180
4 17 1♦, 8◦ & 19 Yes 32 48 64 96 96 112 128 144 160 180
5 21 1♦, 10 & 19• No 16 32 48 64 96 112 128 144 160 180
6 24 1♦, 10 & 19• No 16 32 48 64 96 112 128 144 160 180
7 20 1♦, 10 & 19• No 16 32 48 64 96 112 128 144 160 180
*Blood samples used for T cell characterization, neutrophil phagocytic capacity, lymphocyte gene expression, and plasma cytokine levels. ♦, Cord blood; ◦, Umbilical catheter; ,
Jugular vein puncture; •, Cardiac puncture.
were fed the same relative amounts of diet according to
their body weight. The macronutrient levels in enteral diets
were 33–43 g/L of carbohydrate, 38–52 g/L of fat, and 27–
55 g/L of protein, resulting in 2.6–3.6 MJ/L. An overview
of the different dietary regimens are shown in Table 1. To
prevent diarrhea all animals were given oral antibiotics within
the first 10 days of life. A combination of antibiotics were
used consisting of: amoxicillin with clavulanic acid (Bioclavid,
Sandoz GmbH, Kundl, Austria), gentamicin (Gentocin Vet,
ScanVet, Fredensborg, Denmark) and metronidazole (Flagyl,
Sanofi-aventis, Hørsholm, Denmark), given as 2 doses/day
on day 9 and 10 (litters 1–4) or 2 doses/day on day 1–5
(litter 5–7).
Parenteral nutrition (PN, Kabiven and Vitalipid, Fresenius
Kabi, Uppsala, Sweden) was optimized to preterm piglets and
contained 2.8 MJ/L of energy, 72 g/L of glucose, 31 g/L of lipid,
and 22 g/L of amino acids. PN was provided from birth until
day 7 (decreasing from 120 to 48 ml/kg/day) at which time PN
nutrition was stopped. For litters 1–4, the PN was replaced with a
saline solution to maintain the catheters until blood sampling on
day 8. For litters 5–7 the umbilical catheters were removed after
secession of PN on day 7. The same TPN formulation was used
for all animals, regardless of dietary regimen. On day 10, piglets
were moved to larger individual cages, still with adequate heating
and free access to drinking water (tap water) until euthanasia on
day 19.
Within each litter, fetal growth restricted preterm pigs were
defined as pigs with the lowest 25% birth weight (F-GR, n = 27),
excluding extremely growth restricted piglets below 5% of mean
birth weight (corresponding to ∼350 g, n = 2, due to mortality
shortly after birth) and compared with the remaining pigs in
each litter (F-CON, n = 92). For the evaluation of postnatal
growth restriction until day 19, animals that survived at least
until day 14 were included (n = 109). Within each litter, piglets
with the 25% lowest growth rate, as in relative body weight
increase per day (g/kg/day), from birth to 14 days were defined
as postnatally growth restricted (P-GR, n = 24) and compared
with the remaining pigs in each litter (P-CON, n= 85). Given the
study design, there was an overlap between the fetal and postnatal
growth restricted groups, as illustrated in Table 2.
TABLE 2 | Distribution of pig numbers in groups.
P-GR P-CON Total
F-GR 6 14 20
F-CON 18 71 89
Total 24 85 109
Number of fetal growth restricted preterm pigs and controls (F-GR, F-CON) and,
postnatally growth restricted preterm pigs and controls (P-GR, P-CON).
TABLE 3 | Primers used for qPCR analyses.
Gene Forward primer Reverse primer
TNFA ATTCAGGGATGTGTGGCCTG CCAGATGTCCCAGGTTGCAT
IL2 AAGCTCTGGAGGGAGTGCTA CAACAGCAGTTACTGTCTCATCA
IL4 GTACCAGCAACTTCGTCCAC CCTTCTCCGTCGTGTTCTCT
IL6 TGCCACCTCAGACAAAATGC AGGTTCAGGTTGTTTTCTGCC
IL10 GTCCGACTCAACGAAGAAGG GCCAGGAAGATCAGGCAATA
IFNG AGCTTTGCGTGACTTTGTGT ATGCTCCTTTGAATGGCCTG
TBET CTGAGAGTCGCGCTCAACAA ACCCGGCCACAGTAAATGAC
GATA3 ACCCCTTATTAAGCCCAAGC TCCAGAGAGTCGTCGTTGTG
HPRT1 TATGGACAGGACTGAACGGC ACACAGAGGGCTACGATGTG
Blood Sampling, Body Composition, and
Tissue Collection
Blood samples (∼1.5mL) were collected at different time points,
including cord blood from birth (all litters), in the morning of
day 8 from umbilical catheter (litter 1–4), in the morning of day
10 from jugular vein puncture (litter 5–7) and day 19, either by
jugular vein puncture, in the morning before euthanasia (litter
1–4) or by cardiac puncture at euthanasia (litter 5–7). EDTA
stabilized blood samples were used for hematology, T cell subset
phenotyping, analysis of neutrophil phagocytosis functions and
whole blood gene expressions. EDTA stabilized plasma was used
for cytokine assays and serum for biochemical analyses. On day
19, before euthanasia, animals were anesthetized and subjected
to a full body dual energy X ray absorptiometry (Lunar Prodigy
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scanner, GE Healthcare, Little Chalfont, UK) to determine body
composition. Afterwards all animals were euthanized by an
intracardial injection of pentobarbital (60 mg/kg) after which the
weight of all internal organs was recorded.
Hematology, Blood Biochemistry, and
Systemic Immune Parameters
Hematology and serum biochemistry were performed
using an Advia 2120 hematology system and an Advia
1800 Chemistry System, respectively (Siemens Healthcare
Diagnostics, Tarrytown, NY, USA). For a subgroup of 58
animals (F-GR = 11, F-CON = 47, P-GR = 11, P-CON = 39),
additional evaluation of systemic immune maturation was
performed. T cell characterization, neutrophil phagocytic
function, leucocyte gene expression, and plasma cytokine
levels were determined using EDTA stabilized blood samples
from day 1, 8, and 19. For T cell subset characterization,
erythrocytes from blood samples were lysed (BD lysing
solution, BD Biosciences, USA) and leucocytes were washed
and incubated with fluorescent antibodies against porcine CD3
(PerCP-Cy5.5-conjugated mouse anti-CD3, IgG2a isotype,
BD Bioscience), CD4 (FITC-conjugated mouse anti-pig CD4,
IgG2b isotype, Biorad, Copenhagen, Denmark), and CD8
(PE-conjugated mouse anti-pig CD8, IgG2a isotype, Biorad).
Negative controls included PerCP-Cy5.5-conjugated mouse
IgG2a isotype control (BD Bioscience), PE-conjugated mouse
IgG2a negative control, and FITC-conjugated mouse IgG2b
negative control antibodies (Biorad). Leukocytes were analyzed
by flow cytometry using BD Accuri C6 flow cytometer (BD
Biosciences, USA). Lymphocyte population was gated using
the forward scatter (FSC) and side scatter (SSC) dot plots, and
the lymphocyte subsets were defined as follows: T cells (CD3+
lymphocytes), helper T cells (CD3+CD4+CD8− lymphocytes),
cytotoxic T cells (CD3+CD4−CD8+ lymphocytes). Median
fluorescent index (MFI) was used to estimate surface expression
levels of CD4 and CD8.
Blood neutrophil phagocytosis function was tested by ex vivo
whole blood stimulation with fluorescent marked Escherichia
coli (pHrodo Red E. coli (560/585 nm), using bioparticles
phagocytosis kit for flow cytometry (Thermofisher) for 30min,
followed by FACS analysis, as described previously (26). This
determined the fraction of neutrophils with internalized
bacteria (phagocytic rate) and average load of ingested
bacteria per cell (MFI of pHrodo+ neutrophil population,
phagocytic capacity).
Leucocyte gene expression was evaluated by quantitative
polymerase chain reaction (qPCR) of whole blood mRNA
from 39 blood samples on day 8 (F-GR = 6, F-CON = 33,
P-GR = 9, P-CON = 30) and 37 on day 19 (F-GR = 6,
F-CON = 31, P-GR = 9, P-CON = 28). Briefly, fresh
blood was fixed by addition of a lysis binding solution
(Thermofisher) to fresh whole blood and frozen (−80◦C) for
later processing, as previously described (27). Later, RNA was
extracted (MagMAX 96 Blood RNA Isolation Kit, Thermofisher)
and converted to cDNA according to the manufacturer’s
instructions (High capacity cDNA reverse transcription kit,
Applied Biosystems, USA). We failed to extract RNA from
one sample on day 8 (in F-CON and P-CON groups) and
excluded this from analysis. Using a LightCycler 480 system
(Roche, Switzerland) with a commercial qPCR kit (QuantiTect
SYBR Green PCR Kit, Qiagen, Netherlands), gene expressions
were determined for tumor necrosis factor alpha (TNFA),
interleukin-4 (IL4), interleukin-6 (IL6), interleukin-10 (IL10),
Interferon gamma (IFNG), GATA binding protein-3 (GATA3),
T-box transcription factor TBX21 (TBET), toll-like receptor 2
(TLR2), toll-like receptor 4 (TLR4), and using hypoxanthine
FIGURE 1 | Body weight across the study period in fetal growth restricted
preterm pigs and controls (F-GR, n = 27; F-CON, n = 92, A) and postnatally
growth restricted preterm pigs and controls (P-GR, n = 24; P-CON, n = 85,
B). Values are means with corresponding standard error of the mean.
*p < 0.05, ***p < 0.001.
TABLE 4 | Relative weight (g per kg body weight) of internal organs on day 19.
F-GR, n = 19 F-CON, n = 86 P-GR, n = 24 P-CON, n = 81
Heart 6.8 ± 0.4 6.5 ± 0.1 6.6 ± 0.2 6.5 ± 0.1
Lung 19.1 ± 1.5 18.6 ± 0.6 20.4 ± 1.6(*) 17.8 ± 0.6
Kidney 8.2 ± 0.4(*) 7.2 ± 0.1 7.9 ± 0.3** 7.1 ± 0.1
Adrenals 0.40 ± 0.02*** 0.29 ± 0.01 0.31 ± 0.02 0.30 ± 0.01
Spleen 2.6 ± 0.3 2.8 ± 0.1 2.7 ± 0.3 2.8 ± 0.1
Liver 23.4 ± 1.3 25 ± 0.6 23.5 ± 1.3 24.5 ± 0.6
Stomach 7.7 ± 0.4 6.8 ± 0.1 7 ± 0.3 6.8 ± 0.1
Intestine 40.9 ± 1.8 41.7 ± 0.9 42.6 ± 1.9 42.0 ± 0.9
Colon 17.9 ± 1.8 20 ± 1.2 22.1 ± 2.4 19.4 ± 1.1
Data is presented as means ± SEM. **p < 0.01, ***p < 0.001, (*)p < 0.10 for F-GR
vs. F-CON or P-GR vs. P-CON comparisons, respectively. Data shown for fetal growth
restricted preterm pigs and controls (F-GR, F-CON) and postnatally growth restricted
preterm pigs and controls (P-GR, P-CON). SEM, Standard error of the mean.
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FIGURE 2 | Bone mineral density and bone mineral content (relative to body weight) at euthanasia in fetal growth restricted preterm pigs and controls (F-GR, n = 16;
F-CON, n = 70, A,B) and in postnatally growth restricted preterm pigs and controls (P-GR, n = 20; P-CON, n = 66, C,D). Values are means with corresponding
standard error of the mean. *p < 0.05, ***p < 0.001.
phosphoribosyltransferase 1 (HPRT1) as a housekeeping gene.
Primers were designed using the Genes database and Primer-
BLAST software (both National Center for Biotechnology
Information, USA). All primers used are listed in Table 3.
Samples were run in duplicates with expected 2.5% of variation
of Cq values. For all samples, HPRT1 was quantified within this
variation limit. For the remaining genes, data were excluded
if the variation of Cq values were higher than 2.5%. For
information on the number of censored samples, please see
Supplementary Table 1. Results were presented as fold changes,
relative to expression levels of HPRT1. Ratios of TBET/GATA3,
IL2/IL4, IFNG/IL4, and TNFA/IL6 were used for indication of
type 1 or type 2 T cell polarization (Th1 and Th2, respectively).
The ratio of TNF-α to IL-6 is especially relevant in newborn
infants (28, 29).
Plasma levels of interleukins 2, 6, and 10 (IL-2, IL-6, and IL-
10), C reactive protein (CRP), cortisol and tumor necrosis factor
alpha (TNF-α) were determined using ELISA (porcine specific
duoset kits, R&D Systems). Samples below the detection were
assigned an arbitrary value of half of the detection limit for
statistical analyses.
Statistics
Statistical analyses were performed using Stata 14.2 (StataCorp,
Texas, USA). All data were evaluated for each time point
separately, using linear regression models, with pig group (F-GR
vs. F-CON or P-GR vs. P-CON) and litter as fixed effects. Data
were logarithmically transformed, if necessary. Data without
normal distribution were evaluated by Kruskal–Wallis’ test.
Mortality and group distribution were compared by Chi2 test.
Means and corresponding standard error of means (SEMs)
were reported. P-values <0.05 were considered statistically
significant, and p-values < 0.1 was reported as a tendency to
a difference.
RESULTS
Effects of Fetal Growth Restriction on
Clinical Variables and Organ Development
Birth weight of F-GR piglets were 648 ± 26 vs. 930 ± 17 g
in F-CON pigs (p < 0.001), but the subsequent relative daily
weight gain until day 14 did not differ between the groups (27
± 1 vs. 29 ± 1 g/kg/day). Body weight differed between F-GR
and F-CON piglets for all time points (Figure 1A). Days with
diarrhea (mean 6 days in both groups) and CRP levels (3.2 ±
1.1 vs. 7.2 ± 2.0µg/mL on day 19 for F-GR and F-CON) did
not differ, but mortality was higher in the F-GR group (7 of 27
before day 14 vs. 6 of 95 for F-CON pigs, p < 0.01). On day
19, surviving F-GR pigs had lower body weight (1,113 ± 80
vs. 1,624 ± 41 g, p < 0.001), while relative adrenal gland and
kidney weight was higher (Table 4, p < 0.001 and p = 0.07,
respectively) than in F-CON pigs. Plasma cortisol levels at day
19 did not differ between F-GR and F-CON pigs (23 ± 4 vs. 33
± 8 ng/mL). For body composition, F-GR pigs had lower bone
mineral density and relative bone mineral content than F-CON
pigs (Figures 2A,B, both p < 0.001). Lean body mass (95.3 ±
0.3 vs. 95.4 ± 0.2%) and fat mass (3.9 ± 0.3 vs. 3.7 ± 0.2%)
were similar.
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FIGURE 3 | Development of systemic immune parameters in fetal growth restricted preterm pigs and controls (F-GR, n = 19–24 for A–C and n = 6–10 for D–I;
F-CON, n = 71–89 for A–C and n = 34–37 for D–I), day 1 (cord blood) to day 19. (A–C) leucocyte cell counts, (D–F) fractions of T cell subsets, (G,H) neutrophil
phagocytosis function, I: interleukin-10 levels in plasma (two samples were below detection limit on day 8, both in F-CON group). Values in (A–H) are presented as
means with corresponding standard error of the mean. Values in I are presented as range plots with corresponding means, all analyzed by Kruskal–Wallis’ test.
*p < 0.05.
Effects of Fetal Growth Restriction on
Blood Hematology, Biochemistry, and
Immune Development
F-GR pigs had lower total blood leucocyte counts (Figure 3A,
p < 0.05) at birth, mainly driven by lower lymphocyte counts
(Figure 3C, p = 0.06). Cytotoxic T cell MFI tended to be
higher in F-GR animals (847 ± 120 vs. 768 ± 133, p = 0.06).
No other blood immune cell counts, T cell fractions, T cell
MFI, plasma cytokine levels or markers for blood neutrophil
phagocytic function differed at birth (Figures 3B,D–H). By day
8, only plasma IL-10 levels were higher in F-GR vs. F-CON
pigs (Figure 3I, p < 0.05), whereas all other leucocyte counts
(Figures 3A–C), T cell subsets (Figures 3D–F), neutrophil
phagocytic function (Figures 3G,H) and plasma cytokine levels
and T cell MFI (data not shown) were similar between the two
groups, both at day 8–10 and day 19. Ratios of TNFα/IL-10 did
not differ at any time points.
For all tested leucocyte gene expressions, no differences at day
8 were observed (Figures 4A,C), apart from a tendency to higher
IL10 expression in F-GR, relative to F-CON pigs (Figure 4B,
p = 0.06). By day 19, IL10 expression was lower (Figure 4E,
p< 0.05) and there was a tendency to an increased TBET/GATA3
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FIGURE 4 | Leucocyte gene expression in fetal growth restricted preterm pigs and controls on day 8 (A–C, F-GR, n = 5–6; F-CON, n = 26–32) and 19 (D–F, F-GR,
n = 5–6; F-CON, n = 27–31). (A,D) type 1 helper T cell related genes, (B,E) type 2 helper T cell related genes, (C,F) ratios of type 1 and type 2 helper T cell related
genes. Results presented as mean fold changes in relation to housekeeping gene with corresponding standard error of the mean (A,B,D,E) or as ratios between fold
changes (C,F). *p < 0.05, 9, analyzed by Kruskal–Wallis’ test.
ratio in F-GR pigs (Figure 4F, p = 0.07). Likewise, there was a
tendency toward a lower TNFA/IL10 ratio in F-GR pigs at day 19
(2.9± 1.0 vs. 3.8± 0.9, p= 0.09)
For non-immunological parameters, F-GR pigs showed higher
values of mean platelet volume than F-CON pigs at birth and day
8–10 (MPV, Table 5, both p < 0.05) but no serum biochemical
values at day 19 showed any differences between F-GR and
F-CON pigs.
Effects of Postnatal Growth Restriction on
Clinical Variables and Organ Development
Birth weight did not differ between P-GR and P-CON pigs
(883 ± 37 vs. 883 ± 21 g). P-GR pigs had reduced postnatal
relative weight gain (20 ± 1 vs. 31 ± 1 g/kg/day in P-CON
pigs, p < 0.001), and lower body weight at day 19 (1,357 ±
68 vs. 1,583 ± 48 g in P-CON pigs, p < 0.05). Body weight
started to differ after day 12 (Figure 1B). Days with diarrhea
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TABLE 5 | Hematological parameters at day 1, 8–10, and 19.
Day F-GR
n = 19–24
F-CON
n = 71–89
P-GR
n = 18–23
P-CON
n = 67–80
Erythrocytes (1012 cells/L) 1† 4.1 ± 0.1 4.0 ± 0.0 4.0 ± 0.1 4.1 ± 0.0
8–10 4.1 ± 0.2 4.0 ± 0.1 4.0 ± 0.2 4.1 ± 0.1
19 4.5 ± 0.2 4.5 ± 0.1 4.5 ± 0.1 4.5 ± 0.1
Hemoglobin (mmol/L) 1† 5.5 ± 0.1 5.4 ± 0.0 5.4 ± 0.1 5.5 ± 0.1
8–10 4.8 ± 0.3 4.7 ± 0.1 4.8 ± 0.2 4.8 ± 0.1
19 4.7 ± 0.2 4.7 ± 0.1 4.6 ± 0.2 4.8 ± 0.1
Hematocrit (%) 1† 29.9 ± 0.4 29.5 ± 0.3 29.2 ± 0.4 29.6 ± 0.3
8–10 25.9 ± 1.5 25.1 ± 0.5 25.5 ± 1.1 25.5 ± 0.5
19 25.6 ± 1 26.0 ± 0.5 26.0 ± 1.0 25.9 ± 0.5
MCHC (mmol/L) 1† 18.4 ± 0.3 18.2 ± 0.2 17.7 ± 0.8 18.5 ± 0.1
8–10 18.7 ± 0.4 18.7 ± 0.1 18.7 ± 0.3 18.8 ± 0.1
19 18.6 ± 0.4 18.3 ± 0.3 17.9 ± 0.8 18.5 ± 0.2
MCV (fL) 1† 72.3 ± 1.0 73.5 ± 0.7 72.5 ± 1.1 72.9 ± 0.7
8–10 62.4 ± 1.4 63.2 ± 0.7 63.6 ± 1.2 62.9 ± 0.7
19 57.5 ± 1.2 58.2 ± 0.6 57.5 ± 1.0 58.2 ± 0.7
Platelets (109 cells/L) 1† 187 ± 23 210 ± 11 191 ± 23 201 ± 11
8–10 343 ± 41 359 ± 22 456 ± 56(*) 341 ± 18
19 432 ± 60 487 ± 28 528 ± 65 460 ± 27
MPV (fL) 1† 10.5 ± 0.3* 10.1 ± 0.1 10.2 ± 0.2 10.1 ± 0.1
8–10 13.1 ± 1.3** 10.6 ± 0.4 11.9 ± 1.2 10.5 ± 0.3
19 9.7 ± 0.6 9.6 ± 0.3 9.6 ± 0.6 9.6 ± 0.3
MPC (g/L) 1† 220 ± 2 220 ± 1 219 ± 2 220 ± 1
8–10 224 ± 5 224 ± 2 228 ± 5 223 ± 2
19 228 ± 4 231 ± 2 230 ± 3 230 ± 2
Data is presented as means ± SEM.
†
Cord blood sample; (*)p < 0.1, *p < 0.05, and **p < 0.01 for F-GR vs. F-CON or P-GR vs. P-CON comparisons, respectively. Data shown
for fetal growth restricted preterm pigs and controls (F-GR; F-CON) and postnatally growth restricted preterm pigs and controls (P-GR, P-CON). MCHC, Mean cellular hemoglobin
concentration; MCV, Mean cellular volume; MPV, Mean platelet volume; MPC, Mean platelet component; SEM, Standard error of the mean.
(6–7 days in both groups) and CRP levels (12.1 ± 4.7 vs. 5.2 ±
1.7µg/mL) were similar between P-GR and P-CON pigs. Among
the 20 surviving F-GR pigs, six of themwere categorized as P-GR,
thus the incidence of P-GR did not differ significantly between
F-GR and F-CON pigs (p > 0.1). Relative kidney weight was
increased in P-GR animals (Table 4, p < 0.05) with a tendency
toward increased relative lung weight (Table 4, p = 0.06). For
body composition, bone mineral content was increased in P-GR
pigs (Figure 2D, p< 0.05), while values for bone mineral density
(Figure 2C), lean mass (95.7 ± 0.4 vs. 95.3 ± 0.2%) and fat mass
(3.5± 0.3 vs. 3.8± 0.2%) were similar.
Effects of Postnatal Growth Restriction on
Blood Hematology, Biochemistry, and
Immune Development
At birth, no differences in blood immune cell parameters,
neutrophil phagocytic function, T cell fractions, T cell MFI or
plasma cytokine levels were found between P-GR and P-CON
pigs (Figures 5A–I). By day 8–10, there was higher total blood
leucocyte counts in the P-GR group (Figure 5A, p< 0.05), mainly
driven by increased neutrophil counts (Figure 5B, p < 0.01). In
addition, the neutrophil phagocytic rate (Figure 5G, p < 0.01)
was reduced, with a tendency to improved phagocytic capacity
(Figure 5H, p= 0.05) in P-GR pigs. At day 19, total leucocyte and
neutrophil counts remained higher in P-GR pigs (Figures 5A,B,
both p < 0.05), with a tendency to lower neutrophil phagocytic
rate (Figure 5G, p = 0.08). In addition, monocyte (0.50 ±
0.09 vs. 0.34 ± 0.03 × 109 cells/L, p < 0.05) and eosinophil
(0.16 ± 0.03 vs. 0.09 ± 0.01 × 109 cells/L, p < 0.05) counts, as
well as the fraction of helper T cells (Figure 5E, p < 0.01), were
increased in P-GR animals. Plasma levels of IL-10 (Figure 5I)
or other cytokines, as well as T cell MFI (data not shown)
did not differ at day 8 or 19 between P-GR and P-CON pigs.
Likewise, ratios of TNFα/IL-10 did not vary at any time point.
The P-GR animals tended to have lower platelet counts (Table 5,
p = 0.05) at day 8–10, relative to P-CON pigs. Other than
lower alkaline phosphatase levels in P-GR pigs at day 19, no
biochemical variables or plasma cortisol level differed between
groups (Table 6, p< 0.05).
Leucocyte gene expression at day 8 showed reduced
expression of IL2 (Figure 6A, p < 0.05) and GATA3 (Figure 6B,
p < 0.05), together with a tendency toward an increased ratio
of TNFA to IL6 (Figure 6C, p = 0.08) in P-GR pigs. By day 19
several genes were expressed at numerically lower levels in P-GR
animals, but only TBET (Figure 6D, p < 0.05) expression was
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FIGURE 5 | Development of systemic immune parameters in postnatally growth restricted preterm pigs and controls (P-GR, n = 18–23 for A–C and n = 9–10 for D–I;
P-CON, n = 67–80 for A–C and n = 29–34 for D–I) from day 1 (cord blood) to day 19. (A–C) leucocyte cell counts, (D–F) fractions of T cell subsets, (G,H) neutrophil
phagocytosis function, I: interleukin-10 levels in plasma (two samples were below detection limit on day 8, both in P-CON group). In (A–H), values are presented as
means with corresponding standard error of the mean. In (I), values are presented as range plots with corresponding means, all analyzed by Kruskal–Wallis’ test.
*p < 0.05, **p < 0.01.
significantly down regulated in the P-GR piglets. No differences
were observed for Th2 related factors (Figure 6E). Ratios of
TNFA/IL10 did not differ at any time point between P-GR and
P-CON (data not shown).
DISCUSSION
Preterm infants, especially those born extremely preterm (<28
weeks gestation), show a high sensitivity to infections in the
postnatal period. A large proportion of these are born growth
restricted and show growth deficits after birth due to multiple
maternal, fetal, and postnatal factors (4, 30). It is important
to know if low growth rates are associated with impaired
immune development because this would call for special clinical
interventions to avoid infections. Using preterm pigs as a model
for preterm infants, we show that a moderate growth restriction
at birth, excluding extremely low birth weight preterm pigs,
was associated with increased adrenal gland weight, reduced
bone mineralization, and a transient change in circulating
IL-10 levels. Conversely, slow postnatal growth rates were
associated with modest increases in bone mineralization, blood
neutrophil, monocyte, and eosinophil counts, and a transiently
higher helper T cell fraction. Taken together, surprisingly few
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TABLE 6 | Blood biochemistry at day 19.
F-GR
n = 22
F-CON
n = 81
P-GR
n = 22
P-CON
n = 77
Albumin (g/L) 16.6 ± 0.9 17.6 ± 0.4 17.3 ± 1 17.4 ± 0.4
Total protein (g/L) 27.9 ± 1.2 29.5 ± 0.7 29.4 ± 1.7 29.1 ± 0.6
BUN (mmol/L)9 7.4 ± 0.9 6.8 ± 0.5 8.1 ± 1.0 6.5 ± 0.5
ALAT (U/L) 34 ± 3 32 ± 1 33 ± 2 32 ± 1
AST (U/L)9 50 ± 8 35 ± 2 40 ± 5 37 ± 2
Alkaline phosphatase (U/L) 1,085 ± 122 1,080 ± 63 956 ± 116* 1,117 ± 63
Bilirubin (µmol/L)9 1.3 ± 0.2 1.6 ± 0.2 1.5 ± 0.3 1.6 ± 0.2
GGT (U/L)9 20.1 ± 1.6 22.4 ± 1 21.9 ± 2.3 22.0 ± 0.9
Cholesterol (mmol/L)9 2.5 ± 0.1 2.7 ± 0.1 2.6 ± 0.1 2.6 ± 0.1
Creatine (mmol/L)9 62.5 ± 10.3 53.2 ± 1.4 65.1 ± 9.0 52.1 ± 1.4
Creatine kinase (mmol/L)9 375 ± 145 213 ± 25 223 ± 48 250 ± 43
Glucose (mmol/L)9 4.6 ± 0.5 5.2 ± 0.2 4.8 ± 0.4 5.1 ± 0.2
Lactate (mmol/L)9 4.6 ± 1.0 4.9 ± 0.4 5.1 ± 1.0 4.8 ± 0.4
Sodium (mmol/L)9 140 ± 2 143 ± 2 142 ± 4 143 ± 2
Potassium (mmol/L) 4.4 ± 0.3 4.7 ± 0.1 4.6 ± 0.3 4.6 ± 0.1
Phosphate (mmol/L) 2.3 ± 0.1 2.5 ± 0.1 2.4 ± 0.1 2.5 ± 0.1
Calcium (mmol/L) 2.5 ± 0.1 2.6 ± 0.0 2.5 ± 0.1 2.6 ± 0.0
Magnesium (mmol/L) 0.9 ± 0.0 0.9 ± 0.0 1.0 ± 0.1 0.9 ± 0.0
Iron (mmol/L)9 10.2 ± 1.3 9.1 ± 0.7 9.4 ± 1.2 9.3 ± 0.7
Data is presented as means ± SEM. *p < 0.05 for P-GR vs. P-CON comparison. Ψ , comparison done by Kruskal–Wallis’ test. Data shown for fetal growth restricted preterm pigs and
controls (F-GR, F-CON) and postnatally growth restricted preterm pigs and controls (P-GR, P-CON). ALAT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood
urea nitrogen; GGT, gamma glutaminyl transferase; SEM, standard error of the mean.
parameters differed between F-GR/P-GR and control littermate
pigs, suggesting that moderate growth restriction before or after
preterm birth is not associated with major developmental defects
in the systemic immune system. In addition, postnatal growth
restriction was in fact associated with an increase in several
immune cell types, possibly indicating accelerated immune cell
maturation. However, it remains elusive whether those changes
related to growth restriction may lead to altered immune
competence against infectious challenges. Further studies with
in vivo infection challenges are required to allow conclusion
about mechanisms possibly causing increased risk of infection
in growth restricted infants as previously documented (1, 8–10).
Nevertheless, our data indicate that with appropriate clinical care
and nutrition, moderately growth restricted preterm infants may
show great capacity for short term systemic immune adaptation,
although long term effects are unknown.
Following fetal growth restriction, we found a lower total
leucocyte and lymphocyte counts at birth in F-GR pigs, but
with no differences in T cell subsets or plasma cytokine levels.
By day 8, plasma levels and whole blood gene expressions of
IL-10 were elevated in F-GR pigs. By day 19 however, the
expression of IL10 was reduced in the F-GR animals and the
TBET/GATA3 ratio tended to be increased, possibly indicating
higher Th1 activity. Overall, the leucocyte gene expressions on
day 19 showed lower expressions of most genes. IL-10 has
been considered as an anti inflammatory cytokine produced
by Th2 and regulatory T cells (31), but is also expressed by
many other adaptive and innate immune cells (32). However, IL-
10 production in innate cells is driven primarily by microbial
activation of macrophages and dendritic cells (32, 33). The
lack of clinical, CRP or immune cell responses suggest that
the IL-10 changes observed may be derived from regulatory T
or Th2 cells. Any systemic immune suppressive state shortly
after preterm birth may disappear after 19 days. Such effects
may relate to increased adrenocortical activity after fetal growth
restriction, as indicated by increased relative adrenal gland
weight in F-GR pigs, despite the unaffected basal cortisol levels
detected at day 19. Apparently, the catabolic effects of increased
adrenocortical activity in F-GR piglets did not induce notable
postnatal growth restriction as F-GR pigs were not subject to
more frequent postnatal growth restriction than F-CON pigs.
Likewise, biochemical indices at day 19 were unaffected by the
slow fetal growth rate.
During postnatal growth restriction, bone growth may be
prioritized, supported by the lower levels of alkaline phosphatase,
possibly indicating reduced osteoblastic activity (34). Likewise,
the kidneys appeared to be a prioritized organ in postnatal
growth restricted animals, as indicated by elevated relative weight
on day 19. More importantly, postnatal growth restriction was
associated with changes in immune cell populations. On day 8–10
P-GR animals had higher neutrophil counts, but lower fractions
of neutrophils with phagocytic capacity, suggesting increased
recruitment of immature neutrophils (35, 36). Neutrophils
mature in the bone marrow over a period of 30 days and are
under normal homoeostatic circumstances kept in the bone
marrow as a reserve and slowly released to the circulation,
a process regulated by granulocyte colony stimulation factor
(37). During immunological reactions, these mature neutrophils
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FIGURE 6 | Leucocyte gene expression in postnatally growth restricted preterm pigs and controls, on day 8 (A–C, P-GR, n = 8–9; P-CON, n = 24–29) and 19 (D–F,
P-GR, n = 7–9; P-CON, n = 25–28). (A,D) type 1 helper T cell related genes, (B,E) type 2 helper T cell-related genes, (C,F) ratios of type 1 and type 2 helper T cell
related genes. Results presented as mean fold changes in relation to housekeeping gene with corresponding standard error of the mean (A,B,D,E), or as ratios
between fold changes (C,F). *p < 0.05, 9, analyzed by Kruskal–Wallis’ test.
can be recruited to the circulation under the influence of
other chemotactic agents (38). A higher level of immature
neutrophils in P-GR pigs could indicate a smaller reservoir
of mature neutrophils or an accelerated granulopoiesis. Apart
from neutrophils, monocytes, basophils, eosinophil counts as
well as helper T cell fractions were all elevated in P-GR pigs
at day 19. However, plasma cytokine levels and leucocyte gene
expression were not affected, or even tended to be down regulated
at day 19 in P-GR vs. P-CON pigs. In the absence of clinical
symptoms of infections, as well as few changes in organ weights
and biochemical parameters, the slow growing preterm pigs
managed to support and even increase proliferation of innate
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immune cells. Leucocyte gene expressions on day 8 showed
reduced expression of IL2, a key Th1 cytokine, and GATA3 a
Th2 transcription factor. Thus, it seems that both Th1- and
Th2-related factors were down regulated, while Th1/Th2 ratios
were largely unaffected, apart from a tendency to an increased
TNFA/IL6 ratio. At day 19, a similar pattern of gene expressions
was observed between P-GR and P-CON pigs. Similar to the
trends in F-GR animals, most of the measured genes showed low
mean expressions in the P-GR group. The similarity in leucocyte
gene expression may be partly explained by the overlap of pigs
included into both the P-CON and F-CON groups. On the other
hand, the higher proportion of neutrophils observed in the P-GR
group could also play a role in decreased the expression of the
investigated lymphocyte related genes.
In conclusion, we observed limited effects of moderate
fetal and postnatal growth restriction on organ growth, blood
biochemistry and immune cell development during the first
3 weeks after birth in preterm pigs. We excluded preterm
pigs with extreme growth restriction (<350 g, lowest 5%) due
to mortality shortly after birth, hence our results may be
translationally most relevant for preterm infants without serious
complications and GR in the immediate neonatal period. Our
experimental conditions may have influenced GR effects on some
immune parameters, such as the use of antibiotics, which are
known to influence immune system development (27). Further,
the higher mortality of F-GR piglets during the first weeks
may have differentially affected various immune parameters as
recorded on day 19. Likewise, other than neutrophil phagocytic
capacity, we did not perform ex vivo challenges to immune
cells, so the impact of growth restriction on some immune
cell functions (e.g., cytokine response) is unknown. Finally,
given the overlap in groups and the wide variability in the
leucocyte gene expressions, these data should be interpreted with
caution. Nevertheless, the factors leading to moderate growth
restriction (genetic or environmental influences before or after
birth) did not prevent surviving preterm pigs from following
a near normal immune developmental trajectory, compared to
control animals in the early postnatal period. While extreme
growth restriction (<10% growth percentile) and prematurity
(<28 weeks gestation) may compromise immunity at many
levels, our results indicate that neonates subjected to moderate
growth restriction and immaturity have a remarkable capacity
to adapt their systemic immune system during the first weeks
after birth. The long term effects on cell population, immune
function and susceptibility to infections remain to be elucidated
in future studies.
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